Amrutanjan Health Care Limited

NSE:AMRUTANJAN.NS

781.25 (INR) • At close September 19, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) INR.

202320222021202020192018201720162015201420132012201120102009200820072006
Revenue 3,795.363,795.364,054.4693,315.4832,607.172,519.6862,220.2582,220.3251,867.4351,665.6851,417.2821,366.5631,431.4791,054.039897.697906.604745.491723.877
Cost of Revenue 1,819.791,819.7861,804.6251,401.8521,170.7121,188.932967.735859.959670.355627.538570.049601.528648.15432.554319.413369.546293.284267.722
Gross Profit 1,975.571,975.5742,249.8441,913.6311,436.4581,330.7541,252.5231,360.3651,197.081,038.147847.233765.035783.328621.484578.284537.059452.207456.154
Gross Profit Ratio 0.5210.5210.5550.5770.5510.5280.5640.6130.6410.6230.5980.560.5470.590.6440.5920.6070.63
Reseach & Development Expenses 011.95211.2838.70710.50210.5839.7629.3044.3381.1661.0081.333000000
General & Administrative Expenses 489.69244.61427.27324.36424.41324.41231.17313.8837.962265.72933.76135.794000000
Selling & Marketing Expenses 524.228525.816729.364555.94515.026493.779437.828376.348299.268202.514199.033167.43000000
SG&A 1,013.92525.816756.637580.304539.439518.191469.001390.23307.23468.242508.05167.43000000
Other Expenses 163.483145.4170.66714.4171.3131.2140.017693.5920.0130.0130.013418.07331.244462.1050.3451.5327.4725.405
Operating Expenses 1,584.771,584.7661,450.4241,194.7811,167.5191,035.475985.0011,093.126914.235823.834656.807585.503590.885462.105409.393356.358357.381307.388
Operating Income 390.81418.549798.407717.93267.757293.514267.522331.35326.833243.191193.804154.742192.444159.379168.891180.794.826148.766
Operating Income Ratio 0.1030.110.1970.2170.1030.1160.120.1490.1750.1460.1370.1130.1340.1510.1880.1990.1270.206
Total Other Income Expenses Net 144.65117.905107.359101.11576.78258.15962.03464.1143.98828.8773.379-24.79-34.538-3.37418.449-1.968-7.809-5.986
Income Before Tax 536.45536.454905.766819.045344.539351.673329.556331.35326.833243.191193.804154.742157.906156.005187.341178.73287.017142.78
Income Before Tax Ratio 0.1410.1410.2230.2470.1320.140.1480.1490.1750.1460.1370.1130.110.1480.2090.1970.1170.197
Income Tax Expense 138.11138.105233.877207.14193.706101.696129.064117.258121.07892.45569.36753.57461.55653.88672.623-745.20836.74783.649
Net Income 449.726398.349671.889611.904250.833245.143199.73214.092205.755150.736124.438101.16896.35102.119114.717923.9450.2759.131
Net Income Ratio 0.1180.1050.1660.1850.0960.0970.090.0960.110.090.0880.0740.0670.0970.1281.0190.0670.082
EPS 13.6513.652320.948.588.396.837.467.675.14.263.4616.233.373.7829.051.571.85
EPS Diluted 13.6513.6322.9820.938.588.396.837.467.675.14.263.4616.233.373.7829.051.571.85
EBITDA 518.113589.34950.013863.514379.719382.219341.829334.917357.952282.088236.785218.314229.563179.078182.399196.192115.751163.979
EBITDA Ratio 0.1370.1550.2340.260.1460.1520.1540.1510.1920.1690.1670.160.160.170.2030.2160.1550.227